Hipolin board to consider FY26 results on May 29
Hipolin Limited will hold a board meeting on May 29, 2026, to approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to record the statutory auditor's report.

*this image is generated using AI for illustrative purposes only.
Hipolin Limited has announced that its board of directors will meet on Friday, May 29, 2026. The primary agenda of the meeting is to consider and approve the company's financial performance for the fiscal year ending March 31, 2026.
Agenda for the Meeting
The board will deliberate on the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. In accordance with Regulation 33 of the listing regulations, the directors will also take on record the audit report presented by the statutory auditor.
Regulatory Compliance
The notice regarding the board meeting was issued in compliance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. The company has communicated this schedule to the stock exchanges to ensure timely dissemination of information to the shareholders.
| Meeting Detail | Information |
|---|---|
| Date | May 29, 2026 |
| Purpose | Consideration of Audited Financial Results |
| Period | Quarter and Year ended March 31, 2026 |
| Regulation | SEBI (LODR) Regulations, 2015 |
Historical Stock Returns for Hipolin
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -3.95% | +20.62% | +40.64% | -10.75% | +158.38% |
How does Hipolin Limited's expected FY2026 revenue and profit growth compare to its industry peers in the fast-moving consumer goods or chemical sector?
Will the board consider announcing a dividend or any capital allocation strategy alongside the FY2026 financial results approval?
Are there any pending regulatory investigations or audit qualifications that could impact the clean approval of Hipolin's FY2026 standalone and consolidated results?





























